Brief: AcelRx Pharmaceuticals Announces Presentation Of Investigator-Initiated Trial Results
26/10/2022 14:12
Oct 26 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES PRESENTATION OF
INVESTIGATOR-INITIATED TRIAL RESULTS COMPARING ACELRX'S
SUFENTANIL SUBLINGUAL TABLET (SST) VERSUS INTRAVENOUS OPIOIDS
FOR POSTOPERATIVE PAIN AT THE ANESTHESIOLOGY® ANNUAL MEETING
2022
Source text for Eikon: ID:nPn2nYxGfa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial